Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01395355 · ClinicalTrials.gov registry record · NA
An Integrative Intervention for Loss of Control Eating Among Adolescent Girls
A NA study, sponsored by Virginia Commonwealth University.
- Completed
- Registry status
- NA
- Development phase
- 59
- Enrollment target
NCT01395355: Completed NA study, sponsored by Virginia Commonwealth University.
NCT01395355 is a NA study that has completed, run by Virginia Commonwealth University. The registered enrollment target is 59 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01395355, a NA study, has completed, sponsored by Virginia Commonwealth University.
- COMPLETED
- Registry status
- NA
- Development phase
- 59 participants
- Enrollment target
Study Summary
This study aims to develop a manualized and culturally sensitive intervention for adolescent girls targeting binge and loss of control (LOC) eating. The investigators will evaluate the feasibility and acceptability of the intervention in a controlled pilot trial. The investigators hypothesize that this intervention will serve to reduce binge and LOC eating, as well as improve psychosocial functioning as evidenced by decreased depression, anxiety, eating disorder cognitions, and impulsivity, and improved quality of life.
Interventions
- BEHAVIORAL Linking Individuals Being Emotionally Real (LIBER8)
- BEHAVIORAL Weight Management Control
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 59 participants |
| Start Date | 2011-08 |
| Est. Completion | 2014-12 |
| Phase | NA |
What the finished NCT01395355 record still lists
NCT01395355 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 59 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 2 interventions - of which Linking Individuals Being Emotionally Real (LIBER8) is the first listed.
NCT01395355 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01395355 about?
NCT01395355 is a clinical study titled "An Integrative Intervention for Loss of Control Eating Among Adolescent Girls". This study aims to develop a manualized and culturally sensitive intervention for adolescent girls targeting binge and loss of control (LOC) eating. The investigators will evaluate the feasibility and acceptability of the intervention in a controlled pilot trial. The investigators hypothesize that t...
What is the current status of trial NCT01395355?
This trial is currently completed. It is a NA study. The enrollment target is 59 participants. The study started on 2011-08. Estimated completion is 2014-12.
What interventions are being tested in trial NCT01395355?
The interventions under investigation include: Linking Individuals Being Emotionally Real (LIBER8) (BEHAVIORAL), Weight Management Control (BEHAVIORAL).
Who is sponsoring clinical trial NCT01395355?
This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01395355's enrollment target sits among peer trials
59 1256th of 2000 higher than 745 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03801083 · 59 participants · Phase 2
Adoptive Transfer of Tumor Infiltrating Lymphocytes for Biliary Tract Cancers
- NCT04332367 · 59 participants · Phase 2
Carboplatin, Taxane And Ramucirumab for Patients With NSCLC After Pemetrexed or Pembrolizumab Maintenance
- NCT05489575 · 59 participants · NA
CPAP for the Treatment of Supine Hypertension
- NCT06721689 · 59 participants · Phase 1
PEEL-224, Vincristine and Temozolomide in Pediatric Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia